Literature DB >> 19536759

Generation and characterization of human induced pluripotent stem cells.

Mari Ohnuki1, Kazutoshi Takahashi, Shinya Yamanaka.   

Abstract

This unit describes how to generate human induced pluripotent stem (iPS) cells and evaluate the qualities of the generated iPS cells. The methods for establishment and maintenance of human iPS cells are similar to those for mouse iPS cells but not identical. In addition, these protocols include excellent procedures for passaging and cryopreservation of human iPS cells established by ES cell researchers, which result in an easy way to culture human iPS cells. Moreover, we include methods for characterizing iPS cells for further research. RT-PCR and immunocytochemistry for detection of pluripotent cell markers, embryoid body differentiation, and teratoma differentiation are used to determine pluripotency in vitro and in vivo, respectively. (c) 2009 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19536759     DOI: 10.1002/9780470151808.sc04a02s9

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  51 in total

Review 1.  Thinking outside the liver: induced pluripotent stem cells for hepatic applications.

Authors:  Mekala Subba Rao; Mitnala Sasikala; D Nageshwar Reddy
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

2.  Association of telomere length with authentic pluripotency of ES/iPS cells.

Authors:  Junjiu Huang; Fang Wang; Maja Okuka; Na Liu; Guangzhen Ji; Xiaoying Ye; Bingfeng Zuo; Minshu Li; Ping Liang; William W Ge; John Cm Tsibris; David L Keefe; Lin Liu
Journal:  Cell Res       Date:  2011-02-01       Impact factor: 25.617

3.  Immunocytochemical analysis of human pluripotent stem cells.

Authors:  Hubert E Nethercott; David J Brick; Philip H Schwartz
Journal:  Methods Mol Biol       Date:  2011

4.  Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.

Authors:  Andreas K Nussler; Katrin Zeilinger; Lilianna Schyschka; Sabrina Ehnert; Jörg C Gerlach; Xueying Yan; Serene M L Lee; Maren Ilowski; Wolfgang E Thasler; Thomas S Weiss
Journal:  J Mater Sci Mater Med       Date:  2011-04-03       Impact factor: 3.896

Review 5.  Advances in cellular technology in the hematology field: What have we learned so far?

Authors:  Gustavo Torres de Souza; Claudinéia Pereira Maranduba; Camila Maurmann de Souza; Danielle Luciana Aurora Soares do Amaral; Francisco Carlos da Guia; Rafaella de Souza Salomão Zanette; João Vitor Paes Rettore; Natana Chaves Rabelo; Lucas Mendes Nascimento; Ícaro França Navarro Pinto; Júlia Boechat Farani; Abrahão Elias Hallack Neto; Fernando de Sá Silva; Carlos Magno da Costa Maranduba; Angelo Atalla
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

6.  Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.

Authors:  Gang Wang; Luhan Yang; Dennis Grishin; Xavier Rios; Lillian Y Ye; Yong Hu; Kai Li; Donghui Zhang; George M Church; William T Pu
Journal:  Nat Protoc       Date:  2016-12-08       Impact factor: 13.491

7.  Characterization of pluripotent stem cells.

Authors:  Mercè Martí; Lola Mulero; Cristina Pardo; Cristina Morera; Meritxell Carrió; Leopoldo Laricchia-Robbio; Concepcion Rodriguez Esteban; Juan Carlos Izpisua Belmonte
Journal:  Nat Protoc       Date:  2013-01-10       Impact factor: 13.491

8.  Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation.

Authors:  J Fujikura; K Nakao; M Sone; M Noguchi; E Mori; M Naito; D Taura; M Harada-Shiba; I Kishimoto; A Watanabe; I Asaka; K Hosoda; K Nakao
Journal:  Diabetologia       Date:  2012-03-07       Impact factor: 10.122

9.  EOS lentiviral vector selection system for human induced pluripotent stem cells.

Authors:  Akitsu Hotta; Aaron Y L Cheung; Natalie Farra; Kamal Garcha; Wing Y Chang; Peter Pasceri; William L Stanford; James Ellis
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

10.  Gingival fibroblasts as a promising source of induced pluripotent stem cells.

Authors:  Hiroshi Egusa; Keisuke Okita; Hiroki Kayashima; Guannan Yu; Sho Fukuyasu; Makio Saeki; Takuya Matsumoto; Shinya Yamanaka; Hirofumi Yatani
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.